Remove Avalon Remove Blogging Remove Design Remove Technology
article thumbnail

Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics

Xconomy

Existing investors Avalon Ventures and Correlation Ventures joined in the round. The company’s technology is based on research led by Floyd Romesberg, a biological chemist at The Scripps Research Institute. The San Diego firms have invested $6 million since 2014, when Synthorx was founded , CEO Court Turner said yesterday.

article thumbnail

Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More

Xconomy

CANDID CONVERSATIONS : —Xconomy’s Alex Lash sat down with Cell Design Labs co-founder Wendell Lim to talk about and his work with colleagues at University of California, San Francisco, building “cellbots,” programmable T cells that can sense when they’re near a tumor, and produce drugs on the spot to kill only tumor cells.

Avalon 40